Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Enhancing effect of bromovinyldeoxyuridine on antitumor activity of 5′-deoxy-5-fluorouridine against adenocarcinoma 755 in mice — Akio Hoshi (1989) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Enhancing effect of bromovinyldeoxyuridine on antitumor activity of 5′-deoxy-5-fluorouridine against adenocarcinoma 755 in mice
Shared by
De Clercq Erik
KU Leuven
Enhancing effect of bromovinyldeoxyuridine on antitumor activity of 5′-deoxy-5-fluorouridine against adenocarcinoma 755 in mice
Article
1989
en
Authors
+4 more
AH
Akio Hoshi
NO
Noriko Okudaira
OH
Odagiri Hisashi
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1988
Enhancing effect of bromovinyldeoxyuridine on antitumor activity of 5-fluorouracil against adenocarcinoma 755 in mice
Masaaki Iigo
,
Araki Eiji
,
Yoko Nakajima
,
Akio Hoshi
,
De Clercq Erik
Article
1987
Enhancing effect of bromovinyldeoxyuridine on antitumor activity of 5-fluorouracil and ftorafur against adenocarcinoma 755 in mice
Masaaki Iigo
,
Yoko Nakajima
,
Akio Hoshi
,
De Clercq Erik
Article
1986
Enhancing effect of bromovinyldeoxyuridine on antitumour activity of 5-fluorouracil in mice bearing MOPC-315 plasmacytomas
Shlomo Ben‐Efraim
,
Sigla Shoval
,
De Clercq Erik
Article
1987
The antitumor potency of oral tegafur against adenocarcinoma 755 in mice is markedly enhanced by oral (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Masaaki Iigo
,
Ziro Yamaizumi
,
Susumu Nishimura
,
Akio Hoshi
,
De Clercq Erik
Article
1990
Optimal Treatment Regimens for 5′‐Deoxy‐5‐fluorouridine, with or without (<i>E</i>)‐5‐(2‐Bromovinyl)‐2′‐deoxyuridine, against Various Tumors in Mice
Masaaki Iigo
,
Masanori Miwa
,
De Clercq Erik
Discussion(0)
No comments yet. Be the first to comment.